Read article Working in Europe
The EU is responsible for many important aspects of legislation, from how we look after patients taking part in clinical trials to how our food is labelled. Such legislation is drafted at the EU level and either becomes directly applicable or is passed into national law by the governments of each member state.
Cancer Research UK is the largest independent cancer research organisation in Europe and the European leader in the development of new anti-cancer treatments. In fact, we fund more cancer research than any other organisation in Europe, other than the German Government.
What does Cancer Research UK do?
We monitor the new laws proposed and drafted in Europe. Our experts advise the European Commission and the MEPs in the European Parliament on the best way to make sure that European legislation promotes scientific research and benefits cancer patients. We do this by responding to consultations and working together with other organisations to lobby for legislation and policies that will benefit patients.
We generally focus on the work of the European Commission (who propose new legislation) and the European Parliament (who influence whether it becomes law) although we also work with representatives in the Council of the European Union. To find out how the European process works and our work at the EU level, follow the links below:
- About the European Commission
- About the European Parliament
- About the Council of the European Union
- Committees and intergroups
- International research projects
- European news
The following key documents provide information about Cancer Research UK and our views on EU matters, and can be downloaded:
- Joint letter to Commissioner Ashton about the Tobacco Products Directive (October 2012)
- Cancer Research UK analysis of Clinical Trials Regulation (September 2012)
- WHO discussion paper on multisectoral working
- WHO discussion paper on non-communicable diseases (NCDs)
- UK NCDS and Development Task Force – Response to EU reflection paper on chronic diseases (April 2012)
- Cancer Research UK’s response to EU reflection paper on chronic diseases (April 2012)
- Joint statement on the draft European Data Protection Regulation (March 2012)
- Supporting research, protecting patients: Cancer Research UK’s recommendations to reform the Clinical Trials Directive (February 2012)
- Tobacco Products Directive – myth busting briefing (October 2011)
- Joint statement on clinical trials with other organisations (September 2011)
- Policy statement on the Working Time Directive (June 2011)
- Cancer Research UK response to consultation on VAT (May 2011)
- Response to European Commission green paper on research funding (May 2011)
- Cancer Research UK response to European Commission consultation on clinical trials (May 2011)
- Response to the UK consultation on EU research funding (January 2011)
- Response to consultation on in vitro diagnostic medical devices (September 2010)
- Policy statement on Clinical Trials Directive (September 2010)
- Briefing paper about Cancer Research UK and the EU (August 2011)
- ‘Your Guide to Cancer in Europe’. Please click here for French and German copies of the guide.
Contact us to find out more about our EU activities.
- Share this: Tweet
-
-
- Print this page
-
Email this page
Increase text size
Decrease text size
Print page
